We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BUWA market cap is 6.46B. The company's latest EPS is USD -65.8381 and P/E is -4.04.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.55B | 2.92B | 2.8B | 2.67B | 2.57B |
| Operating Income | 410.96M | 489.43M | 475.12M | 337.8M | 269M |
| Net Income | 3.81B | 4.25B | -3.63B | -637.32M | -1.84B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.97B | 17.78B | 13.5B | 12.3B | 9.36B |
| Total Liabilities | 3.09B | 4.11B | 3.89B | 3.56B | 2.79B |
| Total Equity | 9.88B | 13.67B | 9.62B | 8.74B | 6.57B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 575.33M | 656.52M | 194.45M | 374.9M | 455.2M |
| Investing | -60.25M | -784.44M | -1.21B | 20.21M | -160.2M |
| Financing | -523.04M | -55.43M | 973.58M | -425.65M | -218.8M |
| Market Cap | 6.46B |
| Price to Earnings Ratio | -4.04 |
| Price to Sales Ratio | 2.9 |
| Price to Cash Ratio | 15.25 |
| Price to Book Ratio | 1.13 |
| Dividend Yield | - |
| Shares Outstanding | 28.01M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.2 (0.95%) |
| Company Name | Biorad Labs Inc A Dl 1 |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bio-rad.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
